Cystic fibrosis-related liver disease: Clinical presentations, diagnostic and monitoring approaches in the era of CFTR modulator therapies

This publication has 136 references indexed in Scilit:

• Cancer Risk in Cystic Fibrosis: A 20-Year Nationwide Study From the United States
  JNCI: Journal of the National Cancer Institute, 2012
• Performance of Transient Elastography for the Staging of Liver Fibrosis in Patients with Chronic Hepatitis B: A Meta-Analysis
  PLOS ONE, 2012
• Non-Invasive Evaluation of Cystic Fibrosis Related Liver Disease in Adults with ARFI, Transient Elastography and Different Fibrosis Scores
  PLOS ONE, 2012
• A PPARγ–FGF1 axis is required for adaptive adipose remodelling and metabolic homeostasis
  Nature, 2012
• Secondary causes of nonalcoholic fatty liver disease
  Therapeutic Advances in Gastroenterology, 2011
• Vitamin D receptor agonists inhibit pro-inflammatory cytokine production from the respiratory epithelium in cystic fibrosis
  Journal of Cystic Fibrosis, 2011
• Loss of CFTR Affects Biliary Epithelium Innate Immunity and Causes TLR4–NF-κB—Mediated Inflammatory Response in Mice
  Gastroenterology, 2011
• Pharmacological correction of a defect in PPAR-γ signaling ameliorates disease severity in Cftr-deficient mice
  Nature Medicine, 2010
• Inflammatory cytokines in vascular dysfunction and vascular disease
  Biochemical Pharmacology, 2009
• Noninvasive assessment of liver fibrosis by measurement of stiffness in patients with chronic hepatitis C
  Hepatology, 2004